Mindfulness: a Novel Approach for the Management of Diabetes-related Distress
1 other identifier
interventional
78
1 country
1
Brief Summary
The purpose of this study is to evaluate the impact of stress reduction on physiological and psychological variables in adults with Type 2 diabetes (T2DM) who have moderate to severe levels of diabetes-related emotional distress. Subjects will be randomized to one of two interventions. We will evaluate the impact of the interventions on glucose metabolism, blood pressure, diabetes-related distress and quality of life. Additionally, we will investigate the role of neuroendocrine dysfunction, systemic inflammation and diabetes self-care practices as mediators in the relationship between increased stress, adverse glucose metabolism and elevated blood pressure in those subjects with T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 15, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedApril 19, 2017
April 1, 2017
2.8 years
June 15, 2012
April 17, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
HgA1c
We will assess change in glycemic control using the A1c. It will be measured at baseline, immediately following the 8 week intervention and at 24 weeks from baseline.
0,8,24 weeks
Diabetes Distress
The Problem Areas in Diabetes will be used to assess the change in diabetes emotional distress at baseline, immediately following the 8 week intervention and at 24 weeks from baseline
0,8,24 weeks
Secondary Outcomes (23)
SF36 Physical Health Score
0, 8,24 weeks
SF36 Mental Health Score
0,8,24 weeks
Mean 24 hour ambulatory systolic blood pressure
0,8,24 weeks
Mean 24 hour diastolic ambulatory blood pressure
0,8,24 weeks
HOMA-IR
0,8,24 weeks
- +18 more secondary outcomes
Other Outcomes (1)
Mindfulness
0,8,24 weeks
Study Arms (2)
Mindfulness Based Stress Reduction
EXPERIMENTALHealth Education Control
ACTIVE COMPARATORInterventions
Standard 8-week MBSR program; classes meet for 2.5 hours once weekly The health education control group meets at the same time and for the same amount of time
Eligibility Criteria
You may qualify if:
- Age \> 30 years
- Male or female
- Duration of diabetes 1-15 years from time of initial diagnosis
- Diagnosis of T2DM made/confirmed by physician
- Completed diabetes education in the past
- Most recent HgA1c \>7%; measurement must be within the past 6 months either in physicians office or at the Thriving with Diabetes Boot Camp Class
- Treatment for diabetes must include any or all of the following modalities:
- diet, exercise, oral medications, insulin or other injectable diabetic medication
- Score \> 30 on the Problem Area in Diabetes (PAID) Questionnaire
- Able to use a glucometer for self-monitoring of blood glucose values
- Most recent clinic blood pressure less than 180/95
You may not qualify if:
- History of ketoacidosis
- Age at diagnosis of T2DM \< 30 years
- Score \>15 on the PHQ-9
- Previous training in relaxation or meditation techniques
- Current practice of yoga, tai chi or any other mind-body movement for \> 60 minutes per week
- Current use of a psychoactive drug for less than 3 months or not yet on a stable dose
- Inability to participate fully or behave appropriately in the group treatment setting, as observed by baseline acknowledgement of substance abuse, psychotic episode(s), psychiatric hospitalization or history of self- harm within the past 2 years, or current suicidal or homicidal ideation
- Inability to complete standardized instruments because of a cognitive deficit or language barrier
- Current use or use within the past 3 months of oral glucocorticoids, excluding intraocular, topical or inhaled preparations
- History of inflammatory diseases including rheumatoid arthritis and inflammatory bowel disease
- Use of immune modulating agents
- Night shift work or other type of schedule in which sleep wake cycle is disrupted
- Women who consume \> 7 alcoholic drinks per week and men who consume \> 14 drinks per week
- Current use or history of daily tobacco use within the past 1 year
- End stage renal failure on dialysis
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura A Young, MD, PhD
University of North Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2012
First Posted
March 6, 2013
Study Start
January 1, 2012
Primary Completion
November 1, 2014
Study Completion
December 1, 2015
Last Updated
April 19, 2017
Record last verified: 2017-04